A recent trial described modelling in patients with colorectal cancer and liver metastases where combining circulating nucleosomes levels (24 h post radiation treatment) with pre-therapeutic levels of CRP and AST improved the prognostic model (compared to CRP and AST alone) [113]. This evidence concerns the gene CRP and colorectal cancer.